We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YUMC:NYSEYum China Holdings, Inc. Analysis

Data as of 2026-08-10 - not real-time

$47.72

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Yum China Holdings, Inc. trades at $47.72, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have gained 18.8%. RSI sits at 65.9, which reads as approaching overbought, and MACD momentum is bullish. Watch $42.60 as support and $49.10 as the nearer resistance level.
Multiples put this in fair territory at a P/E of 17.5. The average analyst target implies 30.0% above today's level. Revenue is growing at 12.6% on a 7.8% profit margin. The 2.43% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 23.2%, a beta of 0.36 and a maximum drawdown of 30.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.

Top Market Events

Yum China Holdings, Inc. NYSE:YUMC posted stronger-than-expected second-quarter results on Thursday, with earnings and...Yum China YUMC is well positioned to outperform the market, as it exhibits above-average growth in financials.Is YUMC a good stock to buy? We came across a bullish thesis on Yum China Holdings, Inc. on r/ValueInvesting by...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Trading above the 200-day average of 47.63
  • MACD momentum is positive
  • 30-day price change of +18.8%

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Trading above the 200-day average of 47.63
  • Analyst targets imply +30.0% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Analyst targets imply +30.0% versus the current price
  • Revenue growth of +12.6%
  • P/E ratio of 17.5

Key Metrics & Analysis

Financial Health

Revenue Growth12.60%
Profit Margin7.84%
P/E Ratio17.5
ROE16.81%
ROA8.08%
Debt/Equity30.74
P/B Ratio3.1
Op. Cash Flow$1.6B
Free Cash Flow$1.3B

Technical Analysis

TrendNeutral
RSI65.9
Support$42.60
Resistance$49.10
MA 20$45.28
MA 50$43.58
MA 200$47.63
MACDBullish
VolumeIncreasing
Fear & Greed Index94.82

Valuation

Fair Value$79.33
Target Price$62.05
Upside/Downside30.03%
GradeFair
TypeBlend
Dividend Yield2.43%

Risk Assessment

Beta0.36
Volatility23.23%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.